Robert LeBoyer Stock Analyst Profile - Noble Capital Markets Research Coverage - Stocknear

Robert LeBoyer

Stock Analyst at Noble Capital Markets

(3.45)
# 2676
Out of 5,459 analysts
20
Total ratings
Success rate
Average return
16 Stocks
Name Action PT Current % Upside Ratings Updated
TNXP Tonix Pharmaceutical...
Reiterates: Outperform
70 70
32.18 117.53% 2 Mar 20, 2025
NTRB Nutriband
Initiates Coverage On: Outperform
13
6.41 102.81% 1 Jan 22, 2025
GOVX Geovax Labs
Maintains: Outperform
6 10
0.76 1215.79% 2 Aug 19, 2024
UNCY Unicycive Therapeuti...
Initiates Coverage On: Outperform
60
4.27 1305.15% 1 Feb 14, 2024
CVKD Cadrenal Therapeutic...
Initiates Coverage On: Outperform
60
13.93 330.73% 1 Dec 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
10
2.58 287.6% 1 Sep 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
14
1.66 743.37% 1 Feb 21, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 1 Sep 20, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
150
n/a n/a 1 Oct 12, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
8
1.25 540% 2 Aug 19, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
120
n/a n/a 1 Jan 25, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 1 Oct 5, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
12
9.45 26.98% 1 Sep 28, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
9900000
n/a n/a 1 Aug 24, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 1 Apr 10, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
15
3.59 317.83% 2 Mar 8, 2018